Clinical efficacy of esomeprazole, mosapride, magnesium plus aluminum in reflux esophagitis
10.3969/j.issn.1005-1678.2017.03.065
- VernacularTitle:埃索美拉唑、莫沙必利、镁加铝治疗反流性食管炎的临床效果
- Author:
Tingting XIANG
;
Xingang XU
;
Qingxi XU
- Keywords:
reflux esophagitis;
esomeprazole;
mosapride;
magnesium plus aluminum;
pH
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(3):213-214,218
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate clinical effect of esomeprazole, mosapride, magnesium plus aluminum in patients with reflux esophagitis. Methods 98 patients with reflux esophagitis who were treated in our hospital from October 2014 to October 2016 were selected and randomly divided into control group and observation group, with 49 cases in each group.In the control group, patients were treated with esomeprazole and mosapride.In the observation group, patients were given esomeprazole, mosapride and magnesium plus aluminum.The levels of serum gastrin, serum motilin and 24-hour pH in the esophagus were compared before and after treatment .Results After treatment,The levels of serum gastrin and serum motilin in the observation group were significantly higher than those in the control group, the difference was statistically significant (P<0.05), while the total time percentage of pH<4 at standing position, total time percentage of pH <4 at supine position, total reflux time percentage of pH <4, and the duration of continuous reflux≥five mins in the observation group were significantly lower than those in the control group, the difference was statistically significant (P<0.05). Conclusion Esomeprazole, mosapride and magnesium plus aluminum have significant clinical effect in patients with reflux esophagitis, and can effectively reduce 24-hour pH in the esophagus, decrease the number of reflux, increase serum gastrin and serum motilin levels.
